ASLAN Pharmaceuticals Earning Date (ASLN)

USA |NASDAQ |USD |ADR

ASLN Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
May 9, 2022 Mar 2022 $-0.16 $-0.12 $-0.15
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
May 9, 2022 Mar 2022 $0.00 $0.00 $0.00

Aslan Pharmaceuticals's next earnings date is Monday, May 9, 2022 for the fiscal quarter ending Mar 2022.

ASLN Earnings Date & History Chart

ASLN Earnings & Revenue Forecast

ASLN Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $-0.14 $-0.15 $-0.14
Mar 2022 1 $-0.16 $-0.16 $-0.16
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $-0.48 $-0.49 $-0.47
Dec 2022 3 $-0.53 $-0.68 $-0.42

ASLN Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 2 / 0 $-0.18 $-0.14 $-0.14
Mar 2022 1 / 0 $-0.10 $-0.10 $-0.10
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 2 / 0 $-0.52 $-0.47 $-0.47
Dec 2022 2 / 0 $-0.49 $-0.40 $-0.40

ASLN Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 3 $0.00 $0.00 $0.00
Mar 2022 1 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $0.00 $0.00 $0.00
Dec 2022 3 $0.00 $0.00 $0.00

ASLN Earnings Date & Revenue History

ASLN Earnings History

|
Show More
Show More

ASLN Revenue History

|
Show More
Show More

Aslan Pharmaceuticals Next Earnings Date & Report

ASLN Next Earnings Date & Report Preview: Mar 2022 (FQ)

ASLN's next earnings date is Monday, May 9, 2022 for the fiscal quarter ending Mar 31, 2022.

According to analysts, the average EPS estimation for Aslan Pharmaceuticals's next quarterly earnings is $-0.16, with a low EPS estimation of $-0.16, and a high estimation of $-0.16.

Over the last 1 month, EPS estimates have seen 1 upward revisions and 0 downward. The EPS 1 month trend is $-0.10, the last 2 month trend is $-0.10, and the 3 month trend is $-0.10.

Based on analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Aslan Pharmaceuticals Previous Earnings Dates & Reports

ASLN Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Aslan Pharmaceuticals's previous earnings date was Oct 26, 2021 for its fiscal quarter ended Sep 30, 2021.

ASLN's earnings per share (EPS) was $-0.12, missing the consensus analysts forecast of $-0.09 by -38.41%.

The EPS was lower than the previous fiscal quarter (Jun 2021) by 7.91%, and lower than the same period a year before (Sep 2020) by 20.00%.

Revenues were $0.00.

The company reported a net income of $-8.55M.

ASLN ended the quarter with $31.16M in total debt, an increase of 100.26% compared to the previous quarter, and an increase of 73.09% compared to the same quarter a year before.

ASLN Previous Earnings Date & Report Recap: Dec 2020 (FY)

Aslan Pharmaceuticals's previous annual earnings date was Dec 31, 2020 for its fiscal year ended Dec 31, 2020.

ASLN's earnings per share (EPS) was $-0.45, missing the consensus analysts forecast of $0.00 by % , and higher than the previous year's EPS (Dec 2019) by -68.97%.

Revenues were $0.00.

The company reported a net income of $-16.20M.

Aslan Pharmaceuticals reported a free cash flow of $-15.06M for its fiscal year, compared to $-25.81M a year ago.

The company ended the fiscal year with $18.97M in total debt, an increase of 6.02% compared to the previous year.